Literature DB >> 29474803

Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women.

Matheus Uba Chupel1, Luciele Guerra Minuzzi1, Guilherme Furtado1, Mário Leonardo Santos1, Eef Hogervorst2, Edith Filaire3,4,5, Ana Maria Teixeira1.   

Abstract

Immunosenescence contribute to increase the blood-brain barrier (BBB) permeability, leading cognitive impairment and neurodegeneration. Thus, we investigated the anti-inflammatory effect of exercise and taurine supplementation on peripheral markers of BBB, inflammation, and cognition of elderly women. Forty-eight elderly women (age, 83.58 ± 6.9 years) participated in the study, and were allocated into combined exercise training (CET: n = 13), taurine supplementation (TAU: n = 12), exercise training associated with taurine (CET+TAU: n = 11), or control (CG: n = 12) groups. Exercise was applied twice a week (multi-modal exercise). Taurine ingestion was 1.5 g., once a day. Participants were evaluated before and after 14-weeks of intervention. Plasma levels of interleukin (IL)-1β, IL-1ra, IL-6, IL-10, IL-17, tumor necrosis factor alpha (TNF-α), and serum concentration of S100β and neuron specific enolase (NSE) were determined. The mini mental state examination (MMSE) was also applied. Concentrations of S100β were maintained in all intervention groups, while a subtle increase in the CG was found. NSE levels increased only in TAU group (p < 0.05). CET reduced TNF-α, IL-6, and IL-1β/IL-1ra, IL-6/IL10, and TNF-α/IL-10 ratios (p < 0.05). TAU decreased the IL-1β/IL-1ra ratio (p < 0.05). MMSE score increased only in the CET+TAU group (p < 0.05). Multiple regression analysis showed that there was a trend for changes in IL-1β and the Charlson Comorbidity Index to be independently associated with changes in S100β. Exercise and taurine decreased inflammation, and maintained the BBB integrity in elderly women. Exercise emerged as an important tool to improve brain health even when started at advanced ages.

Entities:  

Keywords:  aging; brain; cerveau; cognition; inflammation; supplementation; supplémentation; taurine; vieillissement

Mesh:

Substances:

Year:  2018        PMID: 29474803     DOI: 10.1139/apnm-2017-0775

Source DB:  PubMed          Journal:  Appl Physiol Nutr Metab        ISSN: 1715-5312            Impact factor:   2.665


  22 in total

1.  Taurine supplementation reduces myeloperoxidase and matrix-metalloproteinase-9 levels and improves the effects of exercise in cognition and physical fitness in older women.

Authors:  Matheus Uba Chupel; Luciele Guerra Minuzzi; Guilherme Eustáquio Furtado; Mário Leonardo Santos; José Pedro Ferreira; Edith Filaire; Ana Maria Teixeira
Journal:  Amino Acids       Date:  2021-02-13       Impact factor: 3.520

Review 2.  Profiling inflammatory and oxidative stress biomarkers following taurine supplementation: a systematic review and dose-response meta-analysis of controlled trials.

Authors:  Amir Hossein Faghfouri; Seyyed Morteza Seyyed Shoura; Pourya Fathollahi; Mahdi Abdoli Shadbad; Shahab Papi; Alireza Ostadrahimi; Elnaz Faghfuri
Journal:  Eur J Clin Nutr       Date:  2021-09-28       Impact factor: 4.884

3.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

4.  Aerobic training improves blood-brain barrier and neuronal apoptosis in experimental autoimmune encephalomyelitis.

Authors:  Omid Razi; Abdolhossein Parnow; Iraj Rashidi; Nafiseh Pakravan; Seyed Ershad Nedaei; Robert W Motl
Journal:  Iran J Basic Med Sci       Date:  2022-02       Impact factor: 2.532

5.  HIV-Tat protein-accelerated aging.

Authors:  Marc J Kaufman; Alaa N Qrareya; Jason J Paris
Journal:  Aging (Albany NY)       Date:  2022-05-27       Impact factor: 5.955

6.  Reversible Symptom Aggravation by Intake of Taurine-Rich Foods in Patients with Venous Congestive Myelopathy: Controlled Case Series Study.

Authors:  Dae Chul Suh; Soo Jeong; Yun Hyeok Choi; Su Min Cho; Su Young Yun; A Yeun Son; Young Min Lim; Boseong Kwon; Yunsun Song
Journal:  Neurointervention       Date:  2022-06-15

7.  Supplemental taurine during adolescence and early adulthood has sex-specific effects on cognition, behavior and neurotransmitter levels in C57BL/6J mice dependent on exposure window.

Authors:  Josephine Brown; Yislain Villalona; Jamie Weimer; Clare Pickering Ludwig; Breann T Hays; Lisa Massie; Cecile A Marczinski; Christine Perdan Curran
Journal:  Neurotoxicol Teratol       Date:  2020-04-11       Impact factor: 3.763

8.  In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brain.

Authors:  Jason J Paris; Xi Chen; Joseph Anderson; Alaa N Qrareya; Fakhri Mahdi; Fei Du; Jay P McLaughlin; Marc J Kaufman
Journal:  Geroscience       Date:  2021-04-05       Impact factor: 7.713

9.  Effects of Moderate Intensity Exercise on the Cortical Thickness and Subcortical Volumes of Preclinical Alzheimer's Disease Patients: A Pilot Study.

Authors:  Yoo Hyun Um; Sheng-Min Wang; Nak-Young Kim; Dong Woo Kang; Hae-Ran Na; Chang Uk Lee; Hyun Kook Lim
Journal:  Psychiatry Investig       Date:  2020-06-15       Impact factor: 2.505

10.  Taurine supplementation in conjunction with exercise modulated cytokines and improved subcutaneous white adipose tissue plasticity in obese women.

Authors:  Flavia Giolo De Carvalho; Camila Fernanda Cunha Brandao; Vitor Rosetto Muñoz; Gabriela Batitucci; Maria Eduarda de Almeida Tavares; Giovana Rampazzo Teixeira; José Rodrigo Pauli; Leandro Pereira De Moura; Eduardo Rochete Ropelle; Dennys Esper Cintra; Adelino Sanchez Ramos da Silva; Márcia Varella Morandi Junqueira-Franco; Julio Sergio Marchini; Ellen Cristini De Freitas
Journal:  Amino Acids       Date:  2021-07-13       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.